Stamos Capital Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.12M Buy
35,451
+1,967
+6% +$298K 0.8% 38
2025
Q4
$4.8M Buy
33,484
+25,316
+310% +$3.73M 0.77% 37
2025
Q3
$1.26M Sell
8,168
-4,479
-35% -$700K 0.24% 99
2025
Q2
$2.01M Buy
12,647
+883
+8% +$144K 0.36% 85
2025
Q1
$2M Sell
11,764
-3,196
-21% -$535K 0.52% 61
2024
Q4
$2.51M Buy
14,960
+290
+2% +$49.4K 0.59% 46
2024
Q3
$2.54M Sell
14,670
-240
-2% -$40.7K 0.6% 50
2024
Q2
$2.46M Sell
14,910
-550
-4% -$89.9K 0.52% 56
2024
Q1
$2.51M Sell
15,460
-1,840
-11% -$289K 0.57% 45
2023
Q4
$2.54M Sell
17,300
-2,460
-12% -$364K 0.69% 40
2023
Q3
$2.88M Buy
19,760
+10
+0.1% +$1.53K 0.64% 48
2023
Q2
$3M Sell
19,750
-1,370
-6% -$206K 0.7% 46
2023
Q1
$3.14M Buy
21,120
+3,440
+19% +$492K 0.81% 36
2022
Q4
$2.68M Buy
17,680
+1,680
+11% +$236K 0.85% 42
2022
Q3
$2.02M Buy
16,000
+8,950
+127% +$1.27M 0.51% 50
2022
Q2
$1.01M Buy
+7,050
New +$1.06M 0.31% 70

Other funds holding PG

Stamos Capital Partners's PG Position: Q1 2026 in Review

Stamos Capital Partners increased its Procter & Gamble (PG) stake by 5.9% in Q1 2026, buying an estimated $298K and bringing the position to 35,451 shares worth $5.12M. The position accounts for 0.8% of the portfolio, ranked #38.

Stamos Capital Partners first reported a position in PG in Q2 2022 and has held it in 16 quarters since. 3,990 funds tracked by Wall St. Rank hold PG as of Q1 2026.

  • Stamos Capital Partners held 35,451 shares of Procter & Gamble worth $5.12M as of Q1 2026.
  • Stamos Capital Partners bought 1,967 Procter & Gamble shares in Q1 2026, an estimated $298K.
  • Procter & Gamble made up 0.8% of Stamos Capital Partners's portfolio in Q1 2026, its #38 holding.
  • Stamos Capital Partners first reported a position in Procter & Gamble in Q2 2022 and has held it in 16 quarters since.
  • 3,990 funds tracked by Wall St. Rank held Procter & Gamble as of Q1 2026.

Based on Stamos Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.